IV Vit C - Integrative Functional Medicine and LDN Community

Integrative Oncology

Evaluating Surgical and Integrative Oncology Options in Early-Stage Breast Carcinoma with Favorable Histology and Multiple Lesions

A Case-Based Review of Attributable Benefit, Attributable Risk, and the Role of Integrative Strategies Alongside Definitive Treatment Yoon Hang Kim, MD, MPH • Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction When a client presents with a new diagnosis of early-stage breast carcinoma, two sets of

Integrative Oncology

Cholangiocarcinoma -A Clinical Overview: Staging, Treatment Algorithm, and an Integrative Oncology Checklist

Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the epithelial lining of the biliary tree. The disease is traditionally divided by anatomic origin into three subtypes: intrahepatic (iCCA, arising from small bile ducts within the liver), perihilar (pCCA, at the hepatic duct confluence), and distal (dCCA, within the extrahepatic bile

IV Vit C

Intravenous Vitamin C with Chemotherapy: Evidence, Protocols, and Practical Guidance for the Integrative Oncology Practitioner

Yoon Hang Kim, MD, MPH • Direct Integrative Care • March 2026 MEDICAL DISCLAIMER This article is for educational and informational purposes only and does not constitute medical advice. Intravenous vitamin C remains investigational for cancer treatment and should not replace standard oncologic therapy. Always consult a qualified healthcare provider before initiating